---
title: "Automated Classification Reveals Most Corrective Actions in Japanese Incident Reports Are Individu"
id: "medrxiv-10-quantifying-the-quality-of-corrective-actions-in-medical-safety-incident"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-10-quantifying-the-quality-of-corrective-actions-in-medical-safety-incident"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1?rss=1"
published_at: "2026-08-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Automated Classification Reveals Most Corrective Actions in Japanese Incident Reports Are Individu
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-10-quantifying-the-quality-of-corrective-actions-in-medical-safety-incident
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1?rss=1)
- **Published At:** 2026-08-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study analysed 11,507 free-text corrective-action entries from Japan's 2010 national medical accident and near-miss database (JCQHC), comprising 8,804 near-miss (Hiyari-Hatto) and 2,703 accident (Jiko) reports. - Developed a five-stage hybrid automated pipeline combining an expert rule dictionary, TF-IDF + k-nearest-neighbor matching, cosine-similarity matching, a two-tier large-language-model (**LLM**) classifier, and a conservative priority-cascade fallback to label each corrective-action entry on a 7-level maturity scale (L0–L6). - Every record received a definitive L0–L6 label (0% unresolved). Overall 16.6% of records were unclassifiable (L0); 9,599 records were classifiable (non-L0). - Among all records, **individual-vigilance** actions (L1) were the most frequent, accounting for 54.6% of records. - The study defined two summary indices: the **Safety Measure Quality Profile (SMQP)** as the full L0–L6 distribution, and the **System-based Safety Measure Rate (SSMR)** as the proportion of non-L0 records classified L3–L6. - Overall SSMR across the dataset was 11.82% (95% CI, 11.19–12.49%). - SSMR was higher for accident reports (18.12%; 95% CI, 16.69–19.64%) than for near-miss reports (value reported in source text was corrupted; precise percentage not reported in the source). The reported risk difference (RD) was 8.66 percentage points, Cramer's V = 0.120, and chi-square(1) = 136.97001. - The between-group difference exceeded the pre-specified minimal clinically important difference (MCID) criteria of RD ≥ 2 percentage points and Cramer's V ≥ 0.10, indicating a substantively higher proportion of system-based actions in accident reports. - The pilot demonstrates feasibility of large-scale automated assessment of corrective-action quality and motivates a planned 16-year longitudinal analysis. The classification dictionary and code were not publicly available at the time of this report because they remain under development and validation, but release is planned after completion of the full study. - Ethics: institutional approval was obtained; requirement for informed consent was waived because data were public and de-identified. The author declared no competing interests.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=e72xLMKCwtgvemPiMXh3ulheBDZGtbWWPYFVZYXNqSQ-1786116451.6109676-1.2.1.1-W1ytCl8Xq0Hf7MZQ329dqPb.AsiNzMIbU_3JC9fDNDw) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Quantifying the Quality of Corrective Actions in Medical Safety Incident Reports Using a Hybrid Rule-Based and Large-Language-Model Classification System: A Cross-Sectional Pilot Feasibility Analysis of 11,507 Japanese National Reports (2010, Interim) [ View ORCID Profile](http://orcid.org/0000-0002-5060-9020)Hitoshi Sugawara doi: https://doi.org/10.64898/2026.08.04.26359750 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Hitoshi Sugawara JADECOM Tokyo-Kita Medical Center * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hitoshi%2BSugawara%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sugawara%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHitoshi%2BSugawara%2B) * [ORCID record for Hitoshi Sugawara](http://orcid.org/0000-0002-5060-9020 "Open in new tab") * For correspondence: hsmdfacp@jichi.ac.jp * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1273586/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1273586/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1273586/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1273586/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1273586/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1273586/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Whether corrective actions documented in medical safety incident reports rely on individual vigilance ("Safety-I") or on structural, system-level intervention ("Safety-II") has not been quantitatively evaluated on a national scale in Japan. We developed an automated classification pipeline to assign corrective-action free-text to a 7-level maturity scale (L0-L6) and computed two summary indices: the Safety Measure Quality Profile (SMQP), the full L0-L6 distribution, and the System-based Safety Measure Rate (SSMR), the proportion of non-L0 records classified L3-L6. Methods: We analyzed all 11,507 corrective-action free-text entries from the 2010 release of Japan's national medical accident and near-miss reporting database (Japan Council for Quality Health Care, JCQHC), comprising 8,804 near-miss (Hiyari-Hatto) and 2,703 accident (Jiko) reports. Records were classified using a five-stage hybrid pipeline: an expert-developed rule dictionary, TF-IDF + k-nearest-neighbor matching, cosine-similarity matching, a two-tier large-language-model (LLM) classifier, and a conservative priority-cascade fallback. SSMR was compared between near-miss and accident reports using a chi-square test, Wilson 95% confidence intervals, Cramer's V, and the risk difference (RD), against pre-specified minimal clinically important difference (MCID) criteria of RD >= 2 percentage points and Cramer's V >= 0.10. Results: Every record received a definitive L0-L6 label (0% unresolved). Overall, 16.6% of records were unclassifiable (L0); among the 9,599 classifiable (non-L0) records, individual-vigilance actions (L1) predominated (54.6% of all records), and only 11.82% (95% CI, 11.19-12.49%) met the SSMR criterion (L3-L6). SSMR was higher for accident reports than for near-miss reports (18.12% [95% CI, 16.69-19.64%] vs. 9.[95% CI,46% [95% CI, 8.80-10.17%]; RD = 8.66 percentage points; Cramer's V = 0.120; chi-square(1) = 136.97001), exceeding both pre-specified MCID thresholds. Conclusions: In this interim single-year analysis, the large majority of documented corrective actions in Japanese medical safety reports remained individual-vigilance-based rather than system-based, with accident reports showing a substantively, rather than merely statistically, higher proportion of system-based actions than near-miss reports. These findings support the feasibility of large-scale automated assessment of corrective-action quality and provide the rationale for the planned 16-year longitudinal analysis. ### Competing Interest Statement The author declares no conflict of interest relevant to this work. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Tokyo-Kita Medical Center Clinical Research Ethics Review Committee of Tokyo-Kita Medical Center gave ethical approval for this work (approval no. 558; approved on 2 July 2026). The requirement for informed consent was waived because this study used publicly available de-identified data and involved no identifiable patient information. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The source data analysed in this study are publicly available from the Japan Council for Quality Health Care (JCQHC) Medical Accident Information Collection Project. Aggregate results are contained within the manuscript and supplementary materials. The classification dictionary, analysis code, and derived datasets are not publicly available at the time of this pilot report because the dictionary remains under active development and validation, but are planned for release following completion of the full study. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.04.26359688v1 "Beyond conventional statistics: Genomic Informational Field Theory \(GIFT\) identifies sex-specific herpes virus associations in multiple sclerosis")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.04.26359671v1 "Emergency-granulopoiesis trajectory, but not the CD4/NK lymphocyte trajectory, is directionally reproduced as a correlate of sepsis mortality: a cross-cohort transcriptomic study with external testing and clinical-analogue triangulation") Posted August 06, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/06/2026.08.04.26359750.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.04.26359750v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/06/2026.08.04.26359750.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Quantifying the Quality of Corrective Actions in Medical Safety Incident Reports Using a Hybrid Rule-Based and Large-Language-Model Classification System: A Cross-Sectional Pilot Feasibility Analysis of 11,507 Japanese National Reports (2010, Interim) Hitoshi Sugawara medRxiv 2026.08.04.26359750; doi: https://doi.org/10.64898/2026.08.04.26359750 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359750v1%26text%3DQuantifying%2520the%2520Quality%2520of%2520Corrective%2520Actions%2520in%2520Medical%2520Safety%2520Incident%2520Reports%2520Using%2520a%2520Hybrid%2520Rule-Based%2520and%2520Large-Language-Model%2520Classification%2520System%253A%2520A%2520Cross-Sectional%2520Pilot%2520Feasibility%2520Analysis%2520of%252011%252C507%2520Japanese%2520National%2520Reports%2520%25282010%252C%2520Interim%2529 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359750v1%26t%3DQuantifying%2520the%2520Quality%2520of%2520Corrective%2520Actions%2520in%2520Medical%2520Safety%2520Incident%2520Reports%2520Using%2520a%2520Hybrid%2520Rule-Based%2520and%2520Large-Language-Model%2520Classification%2520System%253A%2520A%2520Cross-Sectional%2520Pilot%2520Feasibility%2520Analysis%2520of%252011%252C507%2520Japanese%2520National%2520Reports%2520%25282010%252C%2520Interim%2529 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359750v1%26title%3DQuantifying%2520the%2520Quality%2520of%2520Corrective%2520Actions%2520in%2520Medical%2520Safety%2520Incident%2520Reports%2520Using%2520a%2520Hybrid%2520Rule-Based%2520and%2520Large-Language-Model%2520Classification%2520System%253A%2520A%2520Cross-Sectional%2520Pilot%2520Feasibility%2520Analysis%2520of%252011%252C507%2520Japanese%2520National%2520Reports%2520%25282010%252C%2520Interim%2529%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359750v1%26title%3DQuantifying%2520the%2520Quality%2520of%2520Corrective%2520Actions%2520in%2520Medical%2520Safety%2520Incident%2520Reports%2520Using%2520a%2520Hybrid%2520Rule-Based%2520and%2520Large-Language-Model%2520Classification%2520System%253A%2520A%2520Cross-Sectional%2520Pilot%2520Feasibility%2520Analysis%2520of%252011%252C507%2520Japanese%2520National%2520Reports%2520%25282010%252C%2520Interim%2529 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.04.26359750) ## Subject Area * [Health Systems and Quality Improvement ](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (597) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (889) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (322) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4693) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (466) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (403) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (632) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1599) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15672) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1180) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6892) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (719) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1036) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4869) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1414) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1703) * [Hematology](https://www.medrxiv.org/collection/hematology) (568) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1310) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16160) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1149) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (652) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (149) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (706) * [Neurology](https://www.medrxiv.org/collection/neurology) (7056) * [Nursing](https://www.medrxiv.org/collection/nursing) (358) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1060) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1208) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (988) * [Oncology](https://www.medrxiv.org/collection/oncology) (3514) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1016) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (381) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (434) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (457) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (135) * [Pathology](https://www.medrxiv.org/collection/pathology) (696) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1756) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (725) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (751) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5736) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9569) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2332) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1409) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1231) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (628) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (758) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (568) * [Surgery](https://www.medrxiv.org/collection/surgery) (753) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (105) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (300) * [Urology](https://www.medrxiv.org/collection/urology) (278) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers
## Related Clinical Research

- [Revolutionizing Antenatal Care with the Inverted Pyramid Model](https://medichelpline.com/clinical-feed/plos-medicine-1-the-inverted-pyramid-of-care-in-modern-day-obstetrics.md)
- [Pistachios and sleep: what evidence links pistachios to better sleep?](https://medichelpline.com/clinical-feed/medical-news-today-0-are-pistachios-a-natural-way-to-support-sleep-what-the-research-says.md)
- [Statin Use Linked to Reduced Glaucoma Risk in Recent Study](https://medichelpline.com/clinical-feed/medical-news-today-0-statins-may-help-lower-glaucoma-risk-study-finds.md)
- [Why AI for Older Adults Requires Careful Scrutiny, a Geriatrician Warns](https://medichelpline.com/clinical-feed/stat-news-3-stat-a-geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny.md)
- [Emergency post-abortion care experiences at Kawempe National Referral Hospital, Uganda](https://medichelpline.com/clinical-feed/medrxiv-4-women-s-experiences-of-emergency-post-abortion-care-at-kawempe-national.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.